We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BRO:NYSEBrown & Brown, Inc. Analysis

Data as of 2026-06-05 - not real-time

$57.38

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Brown & Brown is currently trading well below its long‑term moving averages, with the price sitting beneath the 20‑day, 50‑day and 200‑day simple moving averages. The 14‑day RSI hovers around the mid‑range, indicating neither extreme overbought nor oversold conditions. Although the MACD line remains negative, the histogram has turned positive, suggesting a nascent bullish momentum despite an overall bearish trend. Volatility remains elevated, reflecting a wide price swing environment, while beta is essentially flat, implying limited correlation with broader market moves. The stock yields a modest dividend with a payout ratio under 25%, supported by strong operating cash flow and free cash flow generation. Recent analyst activity shows a mix of upgrades and target reductions, underscoring a degree of uncertainty around near‑term price direction.
Fundamentally, revenue growth exceeds 30% year‑over‑year and margins are robust, delivering an operating margin above 45% and a solid return on equity. The balance sheet carries substantial debt, but the debt‑to‑equity ratio is moderate for the insurance brokerage sector and cash on hand cushions liquidity. Valuation metrics indicate the market price is well beneath the discounted cash‑flow fair value, implying a sizable upside potential. The dividend yield, while modest, appears sustainable given the low payout and ample cash generation. Overall, the combination of strong earnings fundamentals, attractive valuation, and a resilient dividend supports a longer‑term bullish case. Investors should weigh the heightened short‑term volatility against the longer‑term upside embedded in the fundamentals.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • price near key support level
  • bearish trend with emerging MACD bullish signal
  • mixed analyst sentiment

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • significant valuation upside versus DCF fair value
  • strong revenue growth and high operating margins
  • sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • robust cash flow generation supporting debt service and dividend
  • long‑term industry positioning and diversified broker network
  • persistent undervaluation relative to intrinsic value

Key Metrics & Analysis

Financial Health

Revenue Growth35.70%
Profit Margin18.36%
P/E Ratio18.7
ROE11.93%
ROA5.51%
Debt/Equity64.37
P/B Ratio1.5
Op. Cash Flow$1.5B
Free Cash Flow$1.5B
Industry P/E17.0

Technical Analysis

TrendBearish
RSI46.0
Support$53.81
Resistance$59.71
MA 20$56.78
MA 50$61.57
MA 200$76.60
MACDBullish
VolumeDecreasing
Fear & Greed Index93.93

Valuation

Fair Value$140.76
Target Price$73.00
Upside/Downside27.22%
GradeUndervalued
TypeGrowth
Dividend Yield1.12%

Risk Assessment

Beta-0.01
Volatility34.48%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.